Birmingham, West Midlands -- (SBWIRE) -- 12/09/2013 -- Value Penny Stocks issues special report on Trina Solar Limited (ADR) (NYSE:TSL), Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), GT Advanced Technologies Inc (NASDAQ:GTAT), Novavax, Inc. (NASDAQ:NVAX).
Trina Solar Limited (ADR) (NYSE:TSL) opened its last trade at the price of $13.52. Its closing price was $12.57 after losing -5.91% for the day. The company traded with the total volume of 8.12 million shares, while its average trading volume remained 6.04 million shares. The beta of this stock stands at 3.01. Trina Solar Limited, an integrated solar-power products manufacturer, engages in the design, development, manufacture, and sale of photovoltaic (PV) modules worldwide. The company provides mono- and multi-crystalline silicon ingots, wafers, cells, and related products.
Has TSL Found The Bottom and Ready To Move Up? Find Out Here
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) percentage change surged 11.95% to close at $21.64 with the total traded volume of 7.43 million shares, along with average volume of 1.10 million shares. The 52 week range of the stock remained $13.87 - $22.00, while its day lowest price was $19.323. The share price hit the day highest price of $22.00. Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, focuses on developing and marketing pharmaceutical products in urology and sexual health worldwide.
For How Long AUXL’s Gloss will Attract Investors? Find out via this report
GT Advanced Technologies Inc (NASDAQ:GTAT) traded on volume of 7.41 million shares in the last session against average volume of 6.99 million shares. The company started its trading session with the price of $8.99 and closed at $8.67 by scoring -2.47%. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire.
Why Should Investors Buy GTAT After the Recent Fall? Just Go Here and Find Out
Novavax, Inc. (NASDAQ:NVAX) started its last trading session with the price of $4.08 and closed at $4.23 by scoring +4.70%. The stock traded with total volume of 7.25 million shares, while the average trading volume remained 4.05 million shares. The beta value of this stock stands at 2.41. Day range for the stock was $4.00 - $4.34. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)